Back to Search Start Over

The genomic landscape of 2,023 colorectal cancers.

Authors :
Cornish AJ
Gruber AJ
Kinnersley B
Chubb D
Frangou A
Caravagna G
Noyvert B
Lakatos E
Wood HM
Thorn S
Culliford R
Arnedo-Pac C
Househam J
Cross W
Sud A
Law P
Leathlobhair MN
Hawari A
Woolley C
Sherwood K
Feeley N
Gül G
Fernandez-Tajes J
Zapata L
Alexandrov LB
Murugaesu N
Sosinsky A
Mitchell J
Lopez-Bigas N
Quirke P
Church DN
Tomlinson IPM
Sottoriva A
Graham TA
Wedge DC
Houlston RS
Source :
Nature [Nature] 2024 Sep; Vol. 633 (8028), pp. 127-136. Date of Electronic Publication: 2024 Aug 07.
Publication Year :
2024

Abstract

Colorectal carcinoma (CRC) is a common cause of mortality <superscript>1</superscript> , but a comprehensive description of its genomic landscape is lacking <superscript>2-9</superscript> . Here we perform whole-genome sequencing of 2,023 CRC samples from participants in the UK 100,000 Genomes Project, thereby providing a highly detailed somatic mutational landscape of this cancer. Integrated analyses identify more than 250 putative CRC driver genes, many not previously implicated in CRC or other cancers, including several recurrent changes outside the coding genome. We extend the molecular pathways involved in CRC development, define four new common subgroups of microsatellite-stable CRC based on genomic features and show that these groups have independent prognostic associations. We also characterize several rare molecular CRC subgroups, some with potential clinical relevance, including cancers with both microsatellite and chromosomal instability. We demonstrate a spectrum of mutational profiles across the colorectum, which reflect aetiological differences. These include the role of Escherichia coli <superscript>pks+</superscript> colibactin in rectal cancers <superscript>10</superscript> and the importance of the SBS93 signature <superscript>11-13</superscript> , which suggests that diet or smoking is a risk factor. Immune-escape driver mutations <superscript>14</superscript> are near-ubiquitous in hypermutant tumours and occur in about half of microsatellite-stable CRCs, often in the form of HLA copy number changes. Many driver mutations are actionable, including those associated with rare subgroups (for example, BRCA1 and IDH1), highlighting the role of whole-genome sequencing in optimizing patient care.<br /> (© 2024. The Author(s).)

Details

Language :
English
ISSN :
1476-4687
Volume :
633
Issue :
8028
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
39112709
Full Text :
https://doi.org/10.1038/s41586-024-07747-9